EXPERIMENTAL DATA AND METHODOLOGICAL CONSIDERSATIONS FOR JUSTIFICATION OF IRON OXIDE NANOPARTICLES MAXIMUM ALLOWABLE CONCENTRATION IN OCCUPSATIONAL AIR

Cover Page

Cite item

Full Text

Abstract

Airborne Fe2O3 nanoparticles (NPs) with an average diameter of 14 ± 4 nm, obtained by sparking iron rods of 99.9% purity were fed to a “nose only” type exposition installation for 4 hours 5 times a week over 10 months at an average concentration of 1.14 ± 0.01 mg / m3. A very low accumulation of Fe2O3-NPs in the lung tissue gradually increasing over time was found out. As judged by the almost normal histology of lung and lung-associated lymph nodes and low content of hydroxyproline in the lungs, the intensity of the developing pneumoconiosis was not important. Functional and biochemical indices of the body’s condition mostly remained normal, but some of them made consider tested NP concentration as threshold value in the chronic systemic toxicity. In accordance with general principles of setting MAC for occupational air, it was suggested to consider justified a concentration of 0.4 mg / m3, as MAC value for iron-oxide NPs.

About the authors

M. P. Sutunkova

Ekaterinburg Medical Research Center for Prophylaxis and Health Protection in Industrial Workers, Rospotrebnadzor

Author for correspondence.
Email: noemail@neicon.ru
Russian Federation

References

  1. Katsnelson B.A., Privalova L.I., Kuzmin S.V., Degtyareva T.D., Sutunkova M.P., Yeremenko O.S., Minigalieva I.A., Kireyeva E.P., Khodos M.Y., Kozitsina A.N., Malakhova N.A., Glazyrina J.A., Shur V.Y., Shishkin E.I., Nikolaeva E.V. (2010b) Some peculiarities of pulmonary clearance mechanisms in rats after intratracheal instillation of magnetite (Fe3O4) suspensions with different particle sizes in the nanometer and micrometer ranges: Are we defenseless against nanoparticles? Int J Occup Environ Health 16:508–524
  2. Katsnelson B.A., Degtyareva T.D., Minigalieva I.A., Privalova L.I., Kuzmin S.V., Yeremenko O.S., Kireyeva E.P., Sutunkova M.P., Valamina I.I., Khodos M.Y., Kozitsina A.N., Shur V.Y., Vazhenin V.A., Potapov A.P., Morozova M.V. (2011) Sub-chronic systemic toxicity and bio-accumulation of Fe3O4 nano- and microparticles following repeated intraperitoneal administration to rats. Int J Toxicol 30:60–67
  3. Katsnelson BA, Privalova L.I., Sutunkova M.P., Tulakina L.G., Pichugova S.V., Beykin J.B., Khodos M.J. (2012c) The “in vivo” interaction between iron oxide Fe3О4 nanoparticles and alveolar macrophages. J Bull Exp Biol Med 152:627–631
  4. Szalay B., Kováciková Z., Brózik M., Pándics M., Tátrai E. Effects of iron oxide nanoparticles on pulmonary morphology, redox ystem, production of immunoglobulins and chemokines in rats: in vivo and in vitro studies. CEJOEM 2008, Vol.14. No.2.: 149-164
  5. Soenen S.J., De Cuyper M, De Smedt S.C., Braeckmans K. Investigating the toxic effects of iron oxide nanoparticles. Methods Enzymol. 2012; 509: 195-224.
  6. Ennan, A.A., Kiro, S.A., Oprya, M.V., Vishnyakov, V.I., Particle size distribution of welding fume and its dependency on conditions of shielded metal arc welding. J. Aerosol Sci. 2013: 65, 103-110
  7. Lehnert M., Pesch B., Lotz A., Pelzer J., Kendzia B., Gawrych K., Heinze E., Van Gelder R., Punkenburg E., Weiss T., Mattenklott M., Hahn J.U., Möhlmann C., Berges M., Hartwig A., Brüning T. 2012. Exposure to inhalable, respirable, and ultrafine particles in welding fume. Ann Occup Hyg. 56(5), 557- 567
  8. Lewinski N., Graczyk H., Riediker M., 2013. Human inhalation exposure to iron oxide particles. BioNanoMat, 14(1-2), 5–23
  9. Katsnelson B.A., Privalova L.I., Kuzmin S.V., Gurvich V.B., Sutunkova M.P., Kireyeva E.P., Minigalieva I.A. (2012) An approach to tentative reference levels setting for nanoparticles in the workroom air based on comparing their toxicity with that of their micrometric counterparts: A case study of iron oxide Fe3O4. J ISRN Nanotechnol 2012:12
  10. Sutunkova M.P., Katsnelson B.A., Privalova L.I., Gurvich V.B., Konysheva L.K., Shur V.Y., Shishkina E.V., Minigalieva I.A., Solovjeva S.N., Grebenkina S.V., Zubarev I.V. (2016) On the contribution of the phagocytosis and the solubilization to the iron oxide nanoparticles retention in and elimination from lungs under long-term inhalation exposure. J Toxicol 363:19-28
  11. Bellmann B., Creutzenberg O., Dasenbrock C., 1991. Lung clearance and retention of toner, utilizing a tracer technique, during chronic inhalation exposure in rats. Fundam. Appl. Toxicol. 17, 300-313.
  12. Kolanjiyil A.V., 2013. Deposited nanomaterial mass transfer from lung airways to systemic regions. A thesis for MSc degree. North Carolina State University. Raleigh, NC.
  13. Katsnelson B.A., Konysheva L.K., Privalova L.I., Morosova K.I., 1992. Development of a multicompartmental model of the kinetics of quartz dust in the pulmonary region of the lung during chronic inhalation exposure of rats. Brit. J. Ind. Med. 49, 172-181.
  14. Katsnelson, B.A., Konyscheva, L.K., Sharapova, N.Ye., Privalova, L.I., 1994. Prediction of the comparative intensity of pneumoconiotic changes caused by chronic inhalation exposure to dusts of different cytotoxicity by means of a mathematical model. Occup. Environ. Med. 51, 173-180.
  15. Katsnelson B.A., Konysheva L.K., Privalova L.Y., Sharapova N.Y., 1997. Quartz dust retention in rat lungs under chronic exposure simulated by a multicompartmental model: Further evidence of the key role of the cytotoxicity of quartz particles. Inhalat. Toxicol. 9, 703-715.
  16. Oberdörster G., Sharp Z., Atudore V., Elder A., Gelein R., Kreylin W., 2004. Translocation of inhaled ultrafine particle to the brainI. Inhal. Toxicol. 16 (6/7), 437-445.
  17. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., Potter R., Maynard A., Ito Y., Finkelstein J., Oberdörster G., 2006. Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System. Environ. Health Perspect. 114(8), 1172-1178.
  18. Kao Y.-Y., Cheng T.-J., Yang D.-M., Liu P.-Sh., 2012. Demonstration of an olfactory bulb–brain translocation pathway for ZnO nanoparticles in rodent ells in vitro and in vivo. J. Molecular Neurosci. 48(2), 464-71.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2016 Sutunkova M.P.



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 81728 от 11 декабря 2013.